Magnus S Agren Selected Research

BB 3103

1/2002

Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus S Agren Research Topics

Disease

16	Wounds and Injuries (Trauma) 11/2011 - 01/2002
4	Leg Ulcer 10/2011 - 01/2007
2	Ulcer 09/2011 - 01/2008
2	Pain (Aches) 01/2008 - 09/2006
1	Burns 02/2014
1	Hernia (Hernias) 09/2013
1	Incisional Hernia 09/2013
1	Ischemia 06/2010
1	Surgical Wound 05/2010
1	Diabetic Foot 01/2008
1	Superinfection 01/2007
1	Skin Ulcer 01/2007
1	Infections 09/2006
1	Periodontitis 01/2004
1	Pathologic Constriction (Stenosis) 09/2003
1	Anastomotic Leak 09/2003

Drug/Important Bio-Agent (IBA)

7	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 01/2002
5	CollagenIBA 11/2011 - 11/2002
3	Peptide Hydrolases (Proteases)FDA Link 10/2011 - 01/2004
3	Matrix Metalloproteinase InhibitorsIBA 03/2010 - 01/2002
3	AmelogeninIBA 01/2008 - 01/2004
2	Messenger RNA (mRNA)IBA 11/2011 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 11/2011 - 01/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2007 - 01/2004
2	Zinc Oxide FDA Link 01/2007 - 09/2006
2	ZincIBA 01/2007 - 09/2006
1	Biocompatible Materials (Biomaterials)IBA 02/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2013
1	Metalloproteases (Metalloproteinases)IBA 09/2013
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 11/2011
1	FibrinIBA 11/2011
1	Collagen Type I (Type I Collagen)IBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 10/2011
1	InterleukinsIBA 10/2011
1	ChemokinesIBA 10/2011
1	Interleukin-8 (Interleukin 8)IBA 10/2011
1	CytokinesIBA 10/2011
1	Therapeutic UsesIBA 09/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2011
1	TrypsinIBA 09/2011
1	CathelicidinsIBA 09/2011
1	Pancreatic Elastase (Elastase)IBA 09/2011
1	Oxygen (Dioxygen)IBA 06/2010
1	Isoniazid (Ftivazide)FDA LinkGeneric 06/2010
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2010
1	Procollagen Type IIBA 05/2010
1	Human Serum Albumin FDA LinkGeneric 05/2010
1	AlbuminsIBA 05/2010
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 05/2010
1	Collagen Type III (Type III Collagen)IBA 05/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010
1	batimastat (BB 94)IBA 03/2010
1	Extracellular Matrix ProteinsIBA 01/2008
1	Ointments (Pastes)IBA 01/2007
1	IonsIBA 01/2007
1	EnzymesIBA 01/2007
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 10/2004
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2004
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 10/2004
1	Tryptophan (L-Tryptophan)FDA Link 10/2004
1	propylene glycol alginate ester (propylene glycol alginate)IBA 01/2004
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2002
1	Aprotinin (Trasylol)FDA Link 01/2002
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2002
1	Serine Proteases (Serine Protease)IBA 01/2002
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2002
1	BB 3103IBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2008 - 01/2007
1	Laparotomy 09/2013
1	Catheters 11/2011
1	Laparoscopic Cholecystectomy 05/2010
1	Topical Administration 01/2007